Schizophrenia: Recent Advances in Diagnosis and Treatment

Schizophrenia: Recent Advances in Diagnosis and Treatment

by Philip G. Janicak
     
 

Schizophrenia: Recent Advances in Diagnosis and Treatment is a major addition to the literature, offering practical, comprehensive coverage of diagnosis and treatment options, genetic issues, neuroimaging, long-term management of schizophrenia, and future directions and predictions of how clinical care of schizophrenia will change. The book is divided

…  See more details below

Overview

Schizophrenia: Recent Advances in Diagnosis and Treatment is a major addition to the literature, offering practical, comprehensive coverage of diagnosis and treatment options, genetic issues, neuroimaging, long-term management of schizophrenia, and future directions and predictions of how clinical care of schizophrenia will change. The book is divided into five sections. Section 1 summarizes the present state of knowledge about the diagnosis and treatment of schizophrenia. This includes recent changes in the DSM 5 categorization of schizophrenia and its implications for treatment. Section 2 considers recent discoveries into its pathoetiology, including the status of biological markers, genetics and neuroimaging as they relate to diagnosis and potential novel therapeutic approaches. Section 3 explores the optimization of present therapeutic approaches; novel treatments; and management of the substantial risks associated with both the illness and its present therapies. Section 4 discusses progress in the long-term management of schizophrenia, focusing on biological and psychotherapeutic strategies to improve functioning and facilitate recovery. Section 5 considers future directions and predictions of how diagnosis and treatment of schizophrenia will change. An invaluable addition to the field, Schizophrenia: Recent Advances in Diagnosis and Treatment is a definitive resource that will be of great interest to all clinicians caring for patients with schizophrenia.

Read More

Editorial Reviews

Doody's Review Service
Reviewer: Sean D Conrin, MD (University of Illinois at Chicago College of Medicine)
Description: This book outlines areas of research in schizophrenia to identify progress made to date, areas for future study, and whether current progress might impact clinical decision making.
Purpose: The purpose is to provide an overview of progress in understanding, treating, and developing a conceptualization of directions of study in the field of schizophrenia. These are worthy objectives, because the scope of research in schizophrenia spans many modalities (e.g., basic laboratory, genetics, therapeutics, health policy) and extends far beyond what is possible for individuals to stay abreast of, even with diligent effort. This book is quite effective in meeting its aims as the summaries are clear and succinct, each section includes appropriate commentary to contextualize the information, and actionable information is clearly identified and highlighted.
Audience: The book is written for those who are active in the field of schizophrenia and who wish to gain an overall understanding of current research progress across the various modalities of study. The authors and editors accomplish their objectives.
Features: This book first catches readers up to speed on the overall progress in the field. It then clearly identifies specific areas of research and provides succinct, clear updates in each area of study. The second chapter on the nosology of schizophrenia is particularly helpful to those newer to the field in the way it narrates the evolving conceptualization of schizophrenia over time through its discussion of the context for major revisions of diagnostic guidelines. Another striking feature of this book is the helpful way it summarizes basic research and discusses these findings to connect the dots for readers who do not work in these areas. The strongest aspect of the book might be in this area, as it leaves readers with a clear understanding of how to conceptualize the significance of basic genetic, electrophysiological, and neuroimaging research progress and how this progress is pertinent to the understanding of schizophrenia. In general, this book provides appropriate emphasis on clinical updates based on available research. However, at times, the level of focus and discussion based on available clinical data could be more consistent. For example, the discussion on the potential use of novel interventions (anti-inflammatories, antioxidants) based on smaller studies is useful and clearly illustrated with algorithms and diagrams. At the same time, it would have been useful to discuss more fully the underutilization of clozapine, as the evidence supporting its use is robust and the clinical outcomes are known to be profound.
Assessment: This is an excellent book that would be quite useful to anyone looking for an overview of the progress in schizophrenia to date. It is a solid addition to the literature.

Read More

Product Details

ISBN-13:
9781493906550
Publisher:
Springer New York
Publication date:
05/31/2014
Edition description:
2014
Pages:
331
Product dimensions:
6.10(w) x 9.25(h) x 0.04(d)

Meet the Author

Philip G. Janicak, M.D. Professor of Psychiatry Rush University Chicago, IL Stephen R. Marder, M.D. Professor and Director, Section on Psychosis Semel Institute at UCLA Director, Desert Pacific Mental Illness Research, Education, and Clinical Center VA Greater Los Angeles Healthcare Center Los Angeles, CA Rajiv Tandon, M.D. Professor of Psychiatry, University of Florida College of Medicine Chief of Psychiatry, North Florida/South Georgia V.A. Healthcare System University of Florida College of Medicine Gainesville, FL Morris Goldman, M.D. Associate Professor of Psychiatry Northwestern University Department of Psychiatry Chicago, IL.

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >